Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 984 of 5804
-
Head-to-Head: which JAK inhibitor tames rheumatoid arthritis best?
Disease control Not yet recruitingThe goal of this interventional study is to learn, whether Tofacitinib or upadacitinib is more effective in treating the patients of Rheumatoid Arthritis. It will also learn about the safety of these two agents. The main questions it aims to answer are: * Which JAK inhibitor (To…
Phase: PHASE4 • Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Mindfulness vs. relaxation: which reshapes the anxious brain?
Symptom relief Recruiting nowThis is a randomized controlled trial examining the efficacy and neural mechanisms of a standardized Mindfulness Intervention for Emotional Distress (MIED) in adults with subclinical emotional distress. One hundred and sixty participants will be randomly assigned to either an 8-w…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Healing protein injection could ease back pain without surgery
Disease control Not yet recruitingThe goal of this clinical trial is to find out if a new medicine can help people who have long-lasting back pain caused by damaged spinal discs. The study will also check if the medicine is safe to use. The main questions this study aims to answer are: Is the medicine safe, and…
Phase: PHASE1, PHASE2 • Sponsor: Cartago Biotech Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Laser light could ease knee arthritis without drugs or surgery
Symptom relief Not yet recruitingThis randomized placebo-controlled trial aims to evaluate the effectiveness of High-Intensity Laser Therapy (HILT) as an adjunct to standard outpatient physiotherapy in patients with knee osteoarthritis. Seventy-two participants will be randomly assigned to receive either convent…
Phase: NA • Sponsor: University of Rzeszow • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a common numbing drug cut opioid needs in sickle cell emergencies?
Symptom relief Recruiting nowThe purpose of the study is to determine whether adding lidocaine to standard of care in pain management during severe vaso-occlusive crisis has an effect on the cumulative opioid consumption expressed as morphine milligram equivalent.
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New hope for advanced cancer patients as experimental drug enters trials
Disease control Recruiting nowTo evaluate the safety, tolerability, efficacy and pharmacokinetic characteristics of ICP-B208 in the trial participants of unresectable advanced or metastatic solid tumors
Phase: PHASE1, PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a feeding tube after transplant save the gut?
Disease control Not yet recruitingThis is a randomized controlled phase II trial which will enroll 112 patients with a diagnosis of a blood cancer or a serious blood disorder who plan to undergo an allogenic hematopoietic stem cell transplant using any conditioning regimen or graft source. Eligible patients will …
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for kidney stone sufferers: drug and diet combo tested in major trial
Disease control Recruiting nowThe aim of this randomized trial with a 2-by-2 factorial design is to test the efficacy of the SGLT2 inhibitor empagliflozin and personalized dietary counseling based on 24-hr urine collection results and dietary assessments for kidney stone recurrence prevention in patients with…
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study is open to adults with ST elevation myocardial infarction (heart attack) undergoing primary percutaneous coronary intervention (PCI). The purpose of this study is to determine whether a medicine called Xolatryp is safe and effective in improving cardiac outcomes. One d…
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could red light help breast cancer survivors regrow hair after chemo?
Symptom relief Not yet recruitingThis phase II trial compares the safety and effectiveness of topical minoxidil alone to topical minoxidil in combination with low-level red-light therapy for improving chemotherapy-induced hair loss or thinning (alopecia). Minoxidil has been approved by the Food and Drug Administ…
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New Non-Addictive pain drug could curb opioid dependence after surgery
Disease control Recruiting nowThe purpose of the study is to investigate the efficacy of suzetrigine for treatment of acute postoperative pain among surgical patients identified as high risk for persistent postoperative opioid use (POU). Using a validated artificial intelligence predictive model (termed SurgN…
Phase: PHASE4 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Skull-Implanted device aims to lift severe depression
Disease control Not yet recruitingThe objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).
Phase: NA • Sponsor: Motif Neurotech, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a common diabetes pill help hearts heal after a heart attack?
Disease control Not yet recruitingThis prospective, randomized, open-label, blinded endpoint (PROBE) trial evaluates the efficacy of early ertugliflozin initiation (10 mg daily) compared to standard care alone on cardiac function in 476 adult patients with type 2 diabetes mellitus (T2DM) following a first acute m…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Balloon catheter may catch brain clots during artery stenting
Disease control Not yet recruitingCarotid angioplasty and stenting (CAS) is an effective treatment for carotid artery stenosis but carries a risk of cerebral embolization. This prospective randomized study evaluates the safety and efficacy of proximal embolic protection using a balloon guide catheter during CAS b…
Phase: NA • Sponsor: Instituto de Investigación Marqués de Valdecilla • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Engineered immune cells take on Hard-to-Treat sarcomas
Disease control Recruiting nowThe aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy th…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Brain training app takes on long COVID disability
Symptom relief Not yet recruitingThe goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition. The main question it aims to answer is whether participants as…
Phase: NA • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Antibiotic trial aims to stop COPD attacks by targeting hidden fungus
Disease control Not yet recruitingPrevious researches have found the common colonization of Pneumocystis jirovecii (Pj) in the airways of people with chronic obstructive pulmonary disease (COPD). And this colonization may exacerbate airway inflammation and increase the frequency of acute exacerbation in people wi…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for stubborn eye disease: arthritis drug shows promise
Disease control Not yet recruitingThe aim of the study is to evaluate the efficacy of Baricitinib, a JAK1 and 2 inhibitor, in the management of non-infectious non-anterior uveitis refractory to at least one line of biotherapy (anti-TNF alpha, tocilizumab) after 6 months of treatment
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Modified herpes virus takes on bile duct cancer in new trial
Disease control Not yet recruitingVG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection. Currently, one phase I dose escalation safety study has been completed in China and the United States respectively, both demonstrating excellent safety profiles with no dose-limiting toxicities (DLTs)…
Phase: PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo attack on lung tumors: immunotherapy, radiation, and surgery
Disease control Recruiting nowThis study aims to determine the safety and tolerability of combined Atezolizumab, stereotactic body radiation therapy (SBRT), and surgical resection of pulmonary metastases in patients with pulmonary recurrence of osteosarcoma
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC